mandatory for manufacturers of clinical nutrition products to re-register the baby formulas with
the government, this hampered infant clinical nutrition manufacturers’ growth in China in 2016.
Furthermore, Centre for Food Safety (CFS),in 2017, observed that Similac Stage 2 had 66% less
than the data printed on its nutrition label. Similac Stage 2 should contain 3.8milligrams of
niacin per 100g as was declared, however, its actual content was 1.3 milligrams of niacin per
100g, and due to this the baby milk powder was banned from sale in Hong Kong, which in
turn hampered the clinical nutrition market in Asia Pacific region.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/980
Key companies covered as a part of this study include Nestle, Fresenius Kabi, Abbott Nutrition,
Danone, Baxter Healthcare, and B Braun Melsungen AG.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com